24. Longitudinal Assessment of Immune Responses to COVID-19 Vaccines in Solid Organ Transplant Recipients

BACKGROUND: mRNA vaccines for coronavirus disease 2019 (COVID-19) illicit strong humoral and cellular responses and have high efficacy for preventing and reducing the risk of severe illness from COVID-19. Since solid organ transplant (SOT) recipients were excluded from the phase 3 trials, the effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell, Megan, Sherman, Amy C, Klopfer, Julia, Desjardins, Michaël, Cheng, Chi-An, Senussi, Yasmeen, Ratnaparkhi, Saee, Mitre, Xhoi, Feeley, Monica, Avila Paz, Andres A, Kim, Andy J, Rutherford, Henry, Cauley, Jessica, Kim, Austin, Chang, Jun Bai Park, Liakos, Alexis, Woolley, Ann E, Walt, David, Baden, Lindsey R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644376/
http://dx.doi.org/10.1093/ofid/ofab466.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644376/
http://dx.doi.org/10.1093/ofid/ofab466.024

Ejemplares similares